# Filing Detail

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001005286-24-000030
Filing Date
2024-03-20
Accepted
2024-03-19 20:03:56
Documents
175
Period of Report
2023-05-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-K | lndc-20230528.htm iXBRL | 10-K | 13314412
2 | EX-10.30 | landec-firstamendmenttoc.htm | EX-10.30 | 33370
3 | EX-10.31 | landec-secondamendmentto.htm | EX-10.31 | 34050
4 | EX-10.32 | landec-thirdamendmenttoc.htm | EX-10.32 | 27046
5 | EX-21.1 | lfcr-20230528xex211subsidi.htm | EX-21.1 | 4195
6 | EX-23.1 | lfcr-20230528xex231.htm | EX-23.1 | 4169
7 | EX-31.1 | lfcr-20230528xex31110xk.htm | EX-31.1 | 11143
8 | EX-31.2 | lfcr-20230528xex31210xk.htm | EX-31.2 | 12163
9 | EX-32.1 | lfcr-20230528xex32110xk.htm | EX-32.1 | 7763
10 | EX-32.2 | lfcr-20230528xex32210xk.htm | EX-32.2 | 8488
11 | EX-97.1 | ex971-lifecorecompensation.htm | EX-97.1 | 41551
17 | GRAPHIC | landec-firstamendmenttoc001.jpg | GRAPHIC | 262859
18 |  | landec-firstamendmenttoc002.jpg | GRAPHIC | 262576
19 |  | landec-firstamendmenttoc003.jpg | GRAPHIC | 283932
20 |  | landec-firstamendmenttoc004.jpg | GRAPHIC | 267111
21 |  | landec-firstamendmenttoc005.jpg | GRAPHIC | 233373
22 |  | landec-firstamendmenttoc006.jpg | GRAPHIC | 282753
23 |  | landec-firstamendmenttoc007.jpg | GRAPHIC | 292602
24 |  | landec-firstamendmenttoc008.jpg | GRAPHIC | 124574
25 |  | landec-firstamendmenttoc009.jpg | GRAPHIC | 102890
26 |  | landec-firstamendmenttoc010.jpg | GRAPHIC | 46921
27 |  | landec-firstamendmenttoc011.jpg | GRAPHIC | 35723
28 |  | landec-secondamendmentto001.jpg | GRAPHIC | 258215
29 |  | landec-secondamendmentto002.jpg | GRAPHIC | 204616
30 |  | landec-secondamendmentto003.jpg | GRAPHIC | 275601
31 |  | landec-secondamendmentto004.jpg | GRAPHIC | 273425
32 |  | landec-secondamendmentto005.jpg | GRAPHIC | 289440
33 |  | landec-secondamendmentto006.jpg | GRAPHIC | 269061
34 |  | landec-secondamendmentto007.jpg | GRAPHIC | 287998
35 |  | landec-secondamendmentto008.jpg | GRAPHIC | 105134
36 |  | landec-secondamendmentto009.jpg | GRAPHIC | 100881
37 |  | landec-secondamendmentto010.jpg | GRAPHIC | 45787
38 |  | landec-secondamendmentto011.jpg | GRAPHIC | 26111
39 |  | landec-secondamendmentto012.jpg | GRAPHIC | 98999
40 |  | landec-thirdamendmenttoc001.jpg | GRAPHIC | 228372
41 |  | landec-thirdamendmenttoc002.jpg | GRAPHIC | 232915
42 |  | landec-thirdamendmenttoc003.jpg | GRAPHIC | 245979
43 |  | landec-thirdamendmenttoc004.jpg | GRAPHIC | 237863
44 |  | landec-thirdamendmenttoc005.jpg | GRAPHIC | 300245
45 |  | landec-thirdamendmenttoc006.jpg | GRAPHIC | 33207
46 |  | landec-thirdamendmenttoc007.jpg | GRAPHIC | 100527
47 |  | landec-thirdamendmenttoc008.jpg | GRAPHIC | 48693
48 |  | landec-thirdamendmenttoc009.jpg | GRAPHIC | 29694
49 |  | landec-thirdamendmenttoc010.jpg | GRAPHIC | 143375
50 |  | landec-thirdamendmenttoc011.jpg | GRAPHIC | 73295
| Complete submission text file | 0001005286-24-000030.txt |  | 77712467

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
12 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | lndc-20230528.xsd | EX-101.SCH | 103593
13 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | lndc-20230528_cal.xml | EX-101.CAL | 178931
14 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | lndc-20230528_def.xml | EX-101.DEF | 1064620
15 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | lndc-20230528_lab.xml | EX-101.LAB | 1136472
16 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | lndc-20230528_pre.xml | EX-101.PRE | 1388790
179 | EXTRACTED XBRL INSTANCE DOCUMENT | lndc-20230528_htm.xml | XML | 22373388

Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0528
Type: 10-K | Act: 34 | File No.: 000-27446 | Film No.: 24765862
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)